Image of Jennifer J. Furin

Jennifer J. Furin, MD, PhD

Lecturer on Global Health and Social Medicine

Jennifer Furin, MD, PhD, is an infectious diseases clinician and a medical anthropologist who focuses on global health. She received her PhD in Medical Anthropology from the University of California at Los Angeles in 1995 and her MD from Harvard Medical School in 1999. She completed her residency in internal medicine at Brigham and Women’s Hospital in 2002 and her fellowship in infectious diseases at University Hospitals Case Medical Center (Cleveland) in 2004. Dr. Furin is engaged in clinical and program work and operational research to support the treatment of multidrug-resistant tuberculosis and HIV. She has been fighting drug-resistant TB since 1995 when she began working in Lima, Peru with Partners In Health. She has significant global experience and has done work in Haiti, Peru, Russia, Lesotho, South Africa, Georgia, Bangladesh, Swaziland, and Tajikistan. She is also a member of the Tuberculosis Transformation Science Committee of the AIDS Clinical Trials Group. She serves as a high-level consultant for a number of National TB Programs, WHO, USAID, and Médecins Sans Frontières

Affiliations:

Dr. Furin is also an adjunct assistant professor in the Department of Anthropology at Case Western Reserve University

Dr. Furin is the director of Clinical Capacity Building for the Sentinel Project on Pediatric Drug-Resistant Tuberculosis

Dr. Furin is participating in teaching and research in the Department's Sentinel Project on Pediatric Drug-Resistant Tuberculosis.

Bedaquiline use in South Africa reveals a lifesaving policy in action.
Authors: Authors: Reuter A, Furin J.
Lancet Respir Med
View full abstract on Pubmed
Time to act on injectable-free regimens for children with multidrug-resistant tuberculosis.
Authors: Authors: Seddon JA, Schaaf HS, Marais BJ, McKenna L, Garcia-Prats AJ, Hesseling AC, Hughes J, Howell P, Detjen A, Amanullah F, Singh U, Master I, Perez-Velez CM, Misra N, Becerra MC, Furin JJ.
Lancet Respir Med
View full abstract on Pubmed
Providing quality care on the border with Haiti.
Authors: Authors: Koenig SP, Furin J.
Lancet
View full abstract on Pubmed
Treatment of Multidrug-resistant Tuberculosis Infection in Children.
Authors: Authors: Cruz AT, Garcia-Prats AJ, Furin J, Seddon JA.
Pediatr Infect Dis J
View full abstract on Pubmed
Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis.
Authors: Authors: Harausz EP, Garcia-Prats AJ, Law S, Schaaf HS, Kredo T, Seddon JA, Menzies D, Turkova A, Achar J, Amanullah F, Barry P, Becerra M, Chan ED, Chan PC, Ioana Chiotan D, Crossa A, Drobac PC, Fairlie L, Falzon D, Flood J, Gegia M, Hicks RM, Isaakidis P, Kadri SM, Kampmann B, Madhi SA, Marais E, Mariandyshev A, Méndez-Echevarría A, Moore BK, Nargiza P, Ozere I, Padayatchi N, Ur-Rehman S, Rybak N, Santiago-Garcia B, Shah NS, Sharma S, Shim TS, Skrahina A, Soriano-Arandes A, van den Boom M, van der Werf MJ, van der Werf TS, Williams B, Yablokova E, Yim JJ, Furin J, Hesseling AC.
PLoS Med
View full abstract on Pubmed
Delamanid for rifampicin-resistant tuberculosis: a retrospective study from South Africa.
Authors: Authors: Mohr E, Hughes J, Reuter A, Trivino Duran L, Ferlazzo G, Daniels J, De Azevedo V, Kock Y, Steele SJ, Shroufi A, Ade S, Alikhanova N, Benedetti G, Edwards J, Cox H, Furin J, Isaakidis P.
Eur Respir J
View full abstract on Pubmed
Early safety and efficacy of the combination of bedaquiline and delamanid for the treatment of patients with drug-resistant tuberculosis in Armenia, India, and South Africa: a retrospective cohort study.
Authors: Authors: Ferlazzo G, Mohr E, Laxmeshwar C, Hewison C, Hughes J, Jonckheere S, Khachatryan N, De Avezedo V, Egazaryan L, Shroufi A, Kalon S, Cox H, Furin J, Isaakidis P.
Lancet Infect Dis
View full abstract on Pubmed
Drug-resistant tuberculosis: will grand promises fail children and adolescents?
Authors: Authors: Furin J, Tommasi M, Garcia-Prats AJ.
Lancet Child Adolesc Health
View full abstract on Pubmed
Global programmatic use of bedaquiline and delamanid for the treatment of multidrug-resistant tuberculosis.
Authors: Authors: Cox V, Brigden G, Crespo RH, Lessem E, Lynch S, Rich ML, Waning B, Furin J.
Int J Tuberc Lung Dis
View full abstract on Pubmed
Pan-tuberculosis regimens: an argument against.
Authors: Authors: Dheda K, Gumbo T, Lange C, Horsburgh CR, Furin J.
Lancet Respir Med
View full abstract on Pubmed